Sex difference in the effect of obesity on 24-hour mean serum gonadotropin levels

Hormone and Metabolic Research

Volumn 35, Issue 6, 2003, Pages 362-366

  Strain, G W ^a   Zumoff, Barnett ^b   Miller, L K ^a   Rosner, W ^c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

FSH; LH

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLING; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MEASUREMENT; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; TIME;

ANIMALS; BODY MASS INDEX; CIRCADIAN RHYTHM; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; LUTEINIZING HORMONE; OBESITY; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 0042761943     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41358     Document Type: Article

References (35)

1. Strain GW, Zumoff B, Rosenfeld RS, Levin J, Kream J, Fukushima DK. Mild hypogonadotropic hypogonadism in obese men. Metabolism 1980; 31: 871-875
2. Strain GW, Zumoff B. Unpublished data.
3. Zumoff B. Hormonal abnormalities in obesity. Acta Med Scand 1988; Suppl 723: 153-160
4. Zumoff B, Rosenfeld RS, Strain GW, Levin J, Fukushima DK. Sex differences in the 24-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 1980; 51: 330-333
5. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, Rosenfeld RS. Plasma free and non-SHBG-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 1990; 71: 929-931
6. Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994; 79: 997-1000
7. Knobil E. The neuroendocrine control of the menstrual cycle. Rec Progr Horm Res 1980; 36: 53
8. Bernasconi S, Petraglia F, Iughetti L, Marcellini C, Lamborghini A, Facchinetti F, Genazzini AR. Impaired β-endorphin response to human corticotropin-releasing hormone in obese children. Acta Endocrinol 1988; 119: 7-10
9. Facchinetti F, Bernasconi S, Petraglia F, Marcellini C, Iughetti L, Genazzini AR. Absent β-endorphin response to clonidine in obese children. Horm Metabol Res 1988; 20: 348-351
10. Facchinetti F, Giovannini C, Petraglia F, Barletta C, Comitini G, Genazzini AR. β-endorphin resistance to dexamethasone suppression in obese patients. J Endocrinol Invest 1988; 11: 119-123
11. Giovannini C, Ciucci E, Cassetta MR. β-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss. Horm Metabol Res 1990; 22: 96-100
12. Giugliano D, Cozzolino D, Salvatore T, Torella R, Franchimont P, D'Onofrio F, Lefebvre PJ. Altered metabolic responses to epinephrine and β-endorphin in human obesity. J Clin Endocrinol Metab 1988; 67: 238-244
13. Giugliano D, Cozzolino D, Torella R, Lefebvre PJ, Franchimont P, D'Onofrio F. Persistence of altered metabolic response to β-endorphin after normalization of body weight in obesity. Acta Endocrinol 1991; 124: 159-165
14. Scavo D, Facchinetti F, Barletta C, Petroglia F, Buzzetti R, Monaco M, Giovannini C, Genazzani R. Plasma β-endorphin in response to oral glucose tolerance test in obese patients. Horm Metabol Res 1987; 19: 204-207
15. Scavo D, Barletta C, Buzzetti R, Vagiri D. Effects of caloric restriction and exercise on β-endorphin, ACTH and cortisol circulating levels in obesity. Physical Behavior 1988; 42: 65-68
16. Slowinska-Srzednicka J, Zgliczynski S, Soszynski P. Effect of clonidine on β-endorphin, ACTH and cortisol secretion in essential hypertension and obesity. Eur J Clin Pharmacol 1988; 35: 115-121
17. Balon-Perin S, Kolanowski J, Berbinschi A. The effects of glucose ingestion and fasting on plasma immunoreactive β-endorphin, adrenocorticotropic hormone and cortisol in obese subjects. J Endocrinol Invest 1991; 14: 922-925
18. Rojdmark S, Rossner S. Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting. Metabolism 1991; 40: 191-195
19. Plewe G, Schneider V, Krause V, Beyer J. Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans. J Endocrinol Invest 1987; 10: 137-141
20. Copinschi G, Wegrenka LC, Hane S, Forsham PH. Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metabolism 1967; 16: 485-491
21. Kopelman PG, Noonan K, Goulton R, Forrest AJ. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycemia in obesity. Clin Endocrinol 1985; 23: 87-94
22. Laurian L, Oberman Z, Ayalon D, Cordova T, Herzberg M, Horer E, Harell A. Under-responsiveness of growth hormone secretion after I-DOPA and deep sleep stimulation in obese subjects. Isr J Med Sci 1975; 11: 482-487
23. Tanaka K, Inoue S, Numata K, Okazaki H, Nakamura S, Takamura Y. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and I-DOPA in obesity. Metabolism 1990; 39: 892-896
24. Williams T, Berelowitz M, Joffe SN, Thorner MD, Rivier J, Vale W, Frohman LA. Impaired growth hormone response to growth hormone releasing factor in obesity: a pituitary defect reversed with weight reduction. N Engl J Med 1984; 311: 1403-1407
25. Coiro V, Chiodera P. Effect of obesity and weight loss on the arginine vasopressin response to insulin-induced hypoglycemia. Clin Endocrinol 1987; 27: 253-258
26. Chiodera P, Caprelli L, Caiazza A, Biancomi L, Coiro V. Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking. Metabolism 1990; 39: 783-786
27. Zelissen PM, Koppeschaar HP, Erkelens DW, Thijssen JH. β-endorphin and adrenocortical function in obesity. Clin Endocrinol 1991; 35: 369-372
28. Ghigo E, Procopco M, Boffano GM, Arnat E, Valenti F, Maccario M, Mazza E, Camanni F. Arginine potentiates but does not restore the blunted growth hormone response to growth-hormone-releasing hormone in obesity. Metabolism 1992; 41: 560-563
29. Singh SK, Agrawal JK, RM, Gupta SS. Growth hormone response to clonidine in obese children. Indian Pediatr 1991; 28: 737-740
30. Murnais C, Cordido F, Morales MJ, Casanneva FF, Dieguez C. Corticosteroid-induced growth hormone secretion in normal and obese subjects. Clin Endocrinol 1991; 35: 485-490
31. Tanaka K, Inoue S, Shiraki J, Shishido T, Saito M, Numata K, Takamura Y. Age-related decrease in plasma growth hormone: response to growth hormone-releasing hormone, arginine, and I-DOPA in obesity. Metabolism 1991; 40: 1257-1267
32. Argenio GF, Bernini GP, Sgro M, Vivaldi MS, Oel Corso C, Santoni R, Franchi F. Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of the serotoninergic drug fenfluramine. Metabolism 1991; 40: 724-727
33. Veldhuis JD, Iranmesh A, Ho KK, Waters MJ, Johnson ML, Lizzaralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in men. J Clin Endocrinol Metab 1991; 72: 51-59
34. Cordido F, Dieguez C, Casanueva FF. Effect of central cholinergic neurotransinission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. J Clin Endocrinol Metab 1990; 70: 1361-1370
35. Pijl H, Koppeschaa HP, Willekens FL, Frolich M, Meinders AE. The influence of serotonergic neurotransmission on pituitary hormone release in obese and non-obese females. Acta Endocrinol 1993; 128: 319-324